Amesanar is under clinical development by RHEACELL and currently in Phase II for Diabetic Foot Ulcers. According to GlobalData, Phase II drugs for Diabetic Foot Ulcers does not have sufficient ...

ENERGIF-703 is under clinical development by Energenesis Biomedical and currently in Phase III for Diabetic Foot Ulcers.

Objective We examined associations between ulcer bioburden and ulcer outcomes in neuropathic diabetic foot ulcers (DFUs) that lacked clinical signs of infection. Research Design and Methods Three ...

Most of us suffer some kind of mild reaction after taking prescription and nonprescription medication. But in some cases, the ...

Non-healing wounds may signal gangrene, a severe condition caused by tissue death due to poor oxygen and blood flow. Early ...

This article will review what causes esophageal ulcers, as well as the symptoms, diagnostic process, and treatment options. An esophageal ulcer is a sore or distinct break in the tissue that lines the ...

The colder seasons are not all rosy cheeks and pumpkin spice lattes — it’s also an occasion for blistering cold […] The post ...

An elderly woman was hospitalised in the intensive care unit after going for a traditional Chinese medicine (TCM) treatment three days prior. The family of Liu, 78, are urging the clinic to disclose ...

If you're suffering from foot pain, did you know it could be 71 other issues instead of plantar facitis? Emily learns why ...